biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by roadking08on Sep 01, 2016 5:47pm

198 Views

Post# 25201105

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Abstract

You said it,...Major Mexican standoff.... I say will build a wall at 1.65, a huge wall, a tremendously huge wall, overground, underground with sensors and all.
Beleive me folks, to transcend this wall you will need some major barrier transporter.
Please and before November 8, lets make Bioasis great again

afew2many

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta